Holen Sie sich die Stockscreener-App
4.10
1.91%
-0.09
Handel nachbörslich:
4.08
-0.02
-0.49%
Schlusskurs vom Vortag:
$4.19
Offen:
$4.15
24-Stunden-Volumen:
729.58K
Relative Volume:
0.67
Marktkapitalisierung:
$279.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.81M
KGV:
-2.1809
EPS:
-1.88
Netto-Cashflow:
$74.30M
1W Leistung:
-7.43%
1M Leistung:
-0.96%
6M Leistung:
-41.20%
1J Leistung:
+3.53%
1-Tages-Spanne:
$4.055
$4.19
1-Wochen-Bereich:
$4.055
$4.595
52-Wochen-Spanne:
$2.95
$13.60
Omeros Corporation Stock (OMER) Company Profile
Firmenname
Omeros Corporation
Sektor
Branche
Telefon
206-676-5000
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Vergleichen Sie OMER mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMER
Omeros Corporation
|
4.10 | 285.15M | 0 | -117.81M | 74.30M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-12-08 | Herabstufung | UBS | Buy → Neutral |
| 2022-11-08 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2021-10-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-09-27 | Eingeleitet | JP Morgan | Neutral |
| 2021-02-01 | Eingeleitet | UBS | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-08-21 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-14 | Bestätigt | Maxim Group | Buy |
| 2019-05-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-03-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-03-05 | Herabstufung | Needham | Buy → Hold |
| 2017-11-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Herabstufung | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Bestätigt | Maxim Group | Buy |
| 2017-03-17 | Bestätigt | Needham | Buy |
| 2016-11-16 | Bestätigt | Wedbush | Outperform |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-08-10 | Bestätigt | Maxim Group | Buy |
| 2016-06-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-02 | Bestätigt | Needham | Buy |
| 2016-02-29 | Bestätigt | Wedbush | Outperform |
| 2015-11-11 | Bestätigt | Needham | Buy |
| 2015-08-18 | Bestätigt | WBB Securities | Strong Buy |
| 2015-08-10 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Omeros Corporation Aktie (OMER) Neueste Nachrichten
Quantitative breakdown of Omeros Corporation recent moveWeekly Trend Report & AI Enhanced Execution Alerts - newser.com
Omeros Corporation stock outlook for YEARJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Wealth Enhancement Advisory Services LLC Has $84,000 Stock Holdings in Omeros Corporation $OMER - Defense World
Can Omeros Corporation stock sustain institutional interestBull Run & Capital Efficient Trading Techniques - newser.com
Omeros (NASDAQ:OMER) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
What institutional flow reveals about Omeros CorporationTrade Exit Report & Advanced Swing Trade Entry Plans - newser.com
Lobbying Update: $30,000 of OMEROS CORPORATION lobbying was just disclosed - Quiver Quantitative
Omeros surges 22% on clarity for BLA resubmission for narsoplimab - MSN
How to build a dashboard for Omeros Corporation stockWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Retail investors who hold 53% of Omeros Corporation (NASDAQ:OMER) gained 10%, institutions profited as well - simplywall.st
Mydriasis Market: Epidemiology, Therapies, and Key Players include Théa Laboratories, Omeros Corporation, Ocuphire Pharma. - Barchart.com
Intraday pattern recognizer results for Omeros CorporationJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com
Omeros Corporation stock trend forecast2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
What moving averages say about Omeros CorporationMarket Performance Recap & Real-Time Stock Price Movement Reports - newser.com
Is Omeros Corporation a good long term investmentInsider Buying Signals & Build Wealth With Strategy - earlytimes.in
Using RSI to spot recovery in Omeros CorporationAnalyst Downgrade & Community Verified Watchlist Alerts - newser.com
Omeros Corporation to acquire $80.5 million of its convertible senior notes due 2026 - MSN
Omeros Corporation Completes Promising Phase 2 Study on OMS906 for PNH - TipRanks
What analysts say about Omeros Corporation stockTechnical Breakout Signals & Receive Monthly Expert Trading Blueprints - earlytimes.in
Omeros Corporation (NASDAQ:OMER) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Will Omeros Corporation price bounce be sustainablePortfolio Profit Report & Long-Term Growth Plans - newser.com
Omeros (NASDAQ:OMER) Upgraded at Wall Street Zen - MarketBeat
Goldman Sachs Group Inc. Sells 30,445 Shares of Omeros Corporation $OMER - Defense World
Fund Flows: Will Omeros Corporation benefit from rising consumer demandWeekly Gains Report & Risk Managed Investment Strategies - خودرو بانک
Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN
Omeros (NASDAQ:OMER) Stock Rating Upgraded by Wall Street Zen - Defense World
Omeros Corporation stock trendline breakdownRecession Risk & Accurate Buy Signal Notifications - newser.com
Will Omeros Corporation see short term momentumMarket Movement Recap & Consistent Profit Trading Strategies - newser.com
Real time pattern detection on Omeros Corporation stock2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
Finanzdaten der Omeros Corporation-Aktie (OMER)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):